UBS O'Connor’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

UBS O'Connor’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-786,238	Closed	-$136M	–	1002
2015 Q1	$136M	Buy	+786,238	New	+$115M	2.91%	1

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

UBS O'Connor's SLXP Position: Q2 2015 in Review

UBS O'Connor sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 786,238 shares — an estimated $136M sold.

UBS O'Connor first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $136M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

UBS O'Connor reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
UBS O'Connor sold 786,238 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $136M.
UBS O'Connor first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
UBS O'Connor's SALIX PHARMACEUTICALS LTD DEL position peaked at $136M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.